HSF1 and Familial prostate cancer: In this study a clinical significance of HSF1 in prostate cancer is demonstrated: increased HSF1 expression associates with disease progression and independently predicts initiation of secondary therapy and poor disease-specific survival of prostate cancer patients after radical prostatectomy.